Metformin in heart failure [2]

Diabetes Care

Volumn 30, Issue 12, 2007, Pages

  Inzucchi, Silvio E ^a,d   Masoudi, Frederick A ^b   Mcguire, Darren K ^c  

^a YALE UNIVERSITY   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN;

CARDIOVASCULAR RISK; DRUG SAFETY; HEART FAILURE; HUMAN; INSULIN RESISTANCE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT CONTRAINDICATION;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN;

EID: 37149041388     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1686     Document Type: Letter

References (4)

1. Misbin RI: The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 27:1791-1793, 2004
2. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM: Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure. Circulation 111:583-590, 2005
3. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA: Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 28:2345-2351, 2005
4. Masoudi FA, Inzucchi SE: Diabetes mellitus and heart failure. Am J Cardiol 99:113B-132B, 2007